Type 1 Hypersensitivity clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Allergic Disease Onset Prevention Study

    Sorry, in progress, not accepting new patients

    This is a Phase 1b/2, randomized, double-blind, multi-center study to evaluate the safety, tolerability, and preliminary clinical efficacy of STMC-103H in neonates and infants at risk for developing allergic disease (Type 1 hypersensitivity).…

    San Francisco, California and other locations

Our lead scientists for Type 1 Hypersensitivity research studies include .

Last updated: